Name: Zhong Huijuan
Date of birth: 1961
Type of Business: Pharmaceuticals
Main Achievements: Zhong Huijuan is the chairperson of Hanosh Pharmaceuticals, a Chinese manufacturer of psychoactive, antidiabetic, oncology, and several other kinds of drugs. The billionaire lady is in the acquisition of nearly three fourth of the company’s shares, along with her daughter. In 2019, Hanosh Pharmaceuticals became a publicly-traded and owned company on the Hong Kong Stock Exchange. Zhong appeared on the Forbes Billionaires List of 2020. The renowned entrepreneur enjoys a net worth of $16 billion, as of 2020.
Something interesting about Zhong Huijuan: Not only Zhong, but also her husband is counted among the leading names of Chinese health care sector. His company, Jiangsu Hengrui Medicine, has transformed into one of the most successful manufacturers of tumor-treating and anti-infection drugs. He acquired his company at the age of 32. As of 2020, he had a net worth of $13.8 billion.
Zhong Huijuan was born in China in the year 1961. She is married to Sun Piaoyang, the chairperson of the chairman of Jiangsu Hengrui Medicine. The couple has one child. In 1982, she earned her undergraduate degree in the subject of chemistry from Xuzhou’s Jiangsu Normal University at the age of 21. Following her major, she pursued a career as a chemistry teacher at Yan’an middle school situated in Lianyungang in the early years of the 1990s. However, it was just five years later that the remarkably successful woman laid the foundations of Hanosh in 1995. Zhang withdrew from her teaching job in order to set out on her exceptional entrepreneurial venture.
Zhong built Hanosh pharmaceuticals from scratch and initially hired merely ten employees to run her medicine business. With Zhong’s persistent dedication, the drug store started thriving in the year 1997. It was in the same year that Hanosh achieved sales worth 30 million Yuan. The company started blossoming with every passing year. By 2000, Zhong had succeeded in establishing the first oral formulation factory in Lianyungang. Zhong swept over Wu Yajun, the Chairman of Longfor Group, and acquired the self-made title with her accomplishments. Preceding Yang Huiyan, who is the co-Chairman of Country Garden Holdings, Zhong is the second-richest woman of Asia.
Zhong Huijuan’s company was a product of her relentless effort and remarkable skill. The self-made and competent status is something that sets her apart from several other billionaire women who have inherited their wealth. Her fortune has exceeded her husband’s net worth of $9.4 billion that he has acquired through Jiangsu Hengrui Medicine, a successful pharmaceutical company. Zhong and her husband, Sun Piaoyang, are together counted among the richest pharma families around the world. The two have combined their tremendous hard work to achieve a distinct status in the health care sector. They compete with the Purdue Pharma of the Sackler family as well as Switzerland’s Bertarellis.
Zhong’s company conducts quality researches to manufacture drugs from six areas that include diabetes and cardiovascular, oncology, and psychoactive, etc. The major part of Hanosh’s revenue is generated from its cancer treatment drugs. In 2018, the renowned pharmaceutical company made a profit worth 1.9 billion Yuan. It was 18% greater than the profit reported in the preceding year. As of 2019, the company generated revenue worth 7.7 billion yuan. Singapore’s GIC and Hillhouse Capital are among the investors of Hanosh pharmaceuticals. Zhong, along with her husband’s company, is contributing to lift China’s burden of facing a substantial amount of chronic diseases. China’s healthcare spending has doubled since 2014. Till 2023, it is prospected to surge to 9.4 trillion Yuan. The bolstering sector of health care in China will further provide wind to Zhong’s business’s success.